PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HOLO vs. ICUI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HOLO and ICUI is 0.04, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

HOLO vs. ICUI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MicroCloud Hologram Inc. (HOLO) and ICU Medical, Inc. (ICUI). The values are adjusted to include any dividend payments, if applicable.

-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%AugustSeptemberOctoberNovemberDecember2025
-76.50%
31.84%
HOLO
ICUI

Key characteristics

Sharpe Ratio

HOLO:

-0.08

ICUI:

1.55

Sortino Ratio

HOLO:

6.24

ICUI:

2.67

Omega Ratio

HOLO:

1.66

ICUI:

1.30

Calmar Ratio

HOLO:

-0.95

ICUI:

0.92

Martin Ratio

HOLO:

-1.03

ICUI:

8.57

Ulcer Index

HOLO:

92.20%

ICUI:

7.71%

Daily Std Dev

HOLO:

1,137.61%

ICUI:

42.59%

Max Drawdown

HOLO:

-99.95%

ICUI:

-73.82%

Current Drawdown

HOLO:

-99.88%

ICUI:

-47.65%

Fundamentals

Market Cap

HOLO:

$101.28M

ICUI:

$3.80B

EPS

HOLO:

-$23.66

ICUI:

-$4.56

Total Revenue (TTM)

HOLO:

$128.67M

ICUI:

$1.75B

Gross Profit (TTM)

HOLO:

$23.43M

ICUI:

$595.54M

EBITDA (TTM)

HOLO:

-$133.73M

ICUI:

$197.91M

Returns By Period

In the year-to-date period, HOLO achieves a -38.74% return, which is significantly lower than ICUI's 4.50% return.


HOLO

YTD

-38.74%

1M

70.62%

6M

-81.24%

1Y

-93.79%

5Y*

N/A

10Y*

N/A

ICUI

YTD

4.50%

1M

4.12%

6M

34.84%

1Y

63.06%

5Y*

-2.84%

10Y*

6.80%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HOLO vs. ICUI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HOLO
The Risk-Adjusted Performance Rank of HOLO is 5353
Overall Rank
The Sharpe Ratio Rank of HOLO is 4343
Sharpe Ratio Rank
The Sortino Ratio Rank of HOLO is 9999
Sortino Ratio Rank
The Omega Ratio Rank of HOLO is 9898
Omega Ratio Rank
The Calmar Ratio Rank of HOLO is 11
Calmar Ratio Rank
The Martin Ratio Rank of HOLO is 2323
Martin Ratio Rank

ICUI
The Risk-Adjusted Performance Rank of ICUI is 8686
Overall Rank
The Sharpe Ratio Rank of ICUI is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of ICUI is 8989
Sortino Ratio Rank
The Omega Ratio Rank of ICUI is 8484
Omega Ratio Rank
The Calmar Ratio Rank of ICUI is 7878
Calmar Ratio Rank
The Martin Ratio Rank of ICUI is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HOLO vs. ICUI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for MicroCloud Hologram Inc. (HOLO) and ICU Medical, Inc. (ICUI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HOLO, currently valued at -0.08, compared to the broader market-4.00-2.000.002.00-0.081.55
The chart of Sortino ratio for HOLO, currently valued at 6.24, compared to the broader market-4.00-2.000.002.004.006.242.67
The chart of Omega ratio for HOLO, currently valued at 1.66, compared to the broader market0.501.001.502.001.661.30
The chart of Calmar ratio for HOLO, currently valued at -0.95, compared to the broader market0.002.004.006.00-0.951.13
The chart of Martin ratio for HOLO, currently valued at -1.03, compared to the broader market-10.000.0010.0020.00-1.038.57
HOLO
ICUI

The current HOLO Sharpe Ratio is -0.08, which is lower than the ICUI Sharpe Ratio of 1.55. The chart below compares the historical Sharpe Ratios of HOLO and ICUI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-0.08
1.55
HOLO
ICUI

Dividends

HOLO vs. ICUI - Dividend Comparison

Neither HOLO nor ICUI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HOLO vs. ICUI - Drawdown Comparison

The maximum HOLO drawdown since its inception was -99.95%, which is greater than ICUI's maximum drawdown of -73.82%. Use the drawdown chart below to compare losses from any high point for HOLO and ICUI. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%AugustSeptemberOctoberNovemberDecember2025
-99.88%
-22.47%
HOLO
ICUI

Volatility

HOLO vs. ICUI - Volatility Comparison

MicroCloud Hologram Inc. (HOLO) has a higher volatility of 124.67% compared to ICU Medical, Inc. (ICUI) at 8.44%. This indicates that HOLO's price experiences larger fluctuations and is considered to be riskier than ICUI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%AugustSeptemberOctoberNovemberDecember2025
124.67%
8.44%
HOLO
ICUI

Financials

HOLO vs. ICUI - Financials Comparison

This section allows you to compare key financial metrics between MicroCloud Hologram Inc. and ICU Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab